⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ACNT News
Ascent Industries Co. Common Stock
Accent Therapeutics Presents Data Reinforcing Therapeutic Potential of Novel KIF18A Inhibitor, ATX-295, at the 2026 American Association for Cancer Research Annual Meeting
prnewswire.com
ACNT
Accent Therapeutics to Present Preclinical Data on Lead Clinical Program, ATX-295, at the 2026 American Association for Cancer Research Annual Meeting
prnewswire.com
ACNT
Form 8-K
sec.gov
ACNT
Ascent Industries Appoints Two Proven Specialty Chemicals Leaders to Board of Directors
businesswire.com
ACNT
DD
AXTA
Coca-Cola Southwest Beverages and Texas Monthly Studio Reveal Winners of Star-Spangled Texas Mural Competition
businesswire.com
KO
ACNT
Form 8-K
sec.gov
ACNT
Invest in Others Charitable Foundation Announces 2026 Board of Directors and New Leadership Council
accessnewswire.com
IVZ
BEN
LPL
ACNT
AMP
MS
FIS
MASS
ALL
BLK
RJF
TROW
Form 8-K
sec.gov
ACNT
Ascent Industries Co. Announces Fourth Quarter and Full Year 2025 Results
businesswire.com
ACNT
TeamDynamix Growth Fueled by Migration Away from Legacy ITSM Complexity
businesswire.com
ACNT